VRNA — Verona Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapFalling Star
- $252.34m
- $124.50m
- $40.00m
- 63
- 16
- 41
- 34
Annual cashflow statement for Verona Pharma, fiscal year end - December 31st, millions except per share.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | ||
| Standards: | — | — | USG | USG | USG |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | |||||
| Depreciation | |||||
| Non-Cash Items | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | |||||
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | |||||
| Capital Expenditures | |||||
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | |||||
| Financing Cash Flow Items | |||||
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | |||||
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash |